Skip to main content
. Author manuscript; available in PMC: 2016 Jan 10.
Published in final edited form as: Breast Cancer Res Treat. 2015 Jan 10;149(2):547–554. doi: 10.1007/s10549-014-3260-8

Table 2.

PALB2 missense variants predicted to affect protein function by Align-GVGD and Polyphen2 identified in 1,240 probands participating in the clinic-based resource of the BCFR

Nucleotide changea Protein change rs numberb LOVDc PolyPhen2d Align-GVGD Frequency (n = 1,240) %
PALB2:c.53A>G p.K18R rs138789658 Yes D, 1.000 C0 11 0.89
PALB2:c.2087C>T p.T696M No P, 0.954 C0 1 0.08
PALB2:c.2674G>A p.E892K rs45476495 Yes D, 1.000 C0 3 0.24
PALB2:c.2816T>G p.L939W rs45478192 Yes D, 1.000 C55 7 0.56
PALB2:c.2897T>C p.I966T No D, 1.000 C0 1 0.08
PALB2:c.3054G>C p.E1018D rs183489969 Yes D, 0.998 C0 1 0.08
PALB2:c.3061G>A p.G1021R rs143808171 Yes D, 1.000 C65 1 0.08
PALB2:c.3278T>C p.I1093T rs45616636 Yes D, 0.999 C25 1 0.08
PALB2:c.3356T>C p.L1119P Yes D, 1.000 C65 1 0.08
PALB2:c.3513G>C p.L1171F No D, 1.000 C0 1 0.08
a

Number based on transcript sequence LRG_308; NM_024675.3, +1 as A of ATG start codon

b

rs number from dbSNP v.137

c

Present (yes) or absent (no) from the LOVD v.2.0 Build 36, PALB2 version 140217 [29]

d

PolyPhen2 prediction (D probably damaging, P possibly damaging), PolyPhen2 score [23]